Biventricular Assistance for Chronic Heart Failure

Heart Failure Burden

Over 23 million people worldwide live with heart failure. This number increases by more than 500.000 each year. Many patients progress to advanced stages of the disease where symptoms like shortness of breath at rest or fatigue occur. Frequent hospitalizations are necessary. The number of patients by far exceeds the currently available treatment options.


AdjuCor develops new extravascular devices for individualized biventricular augmentation of the failing heart. The company’s mission is to enable such patients to regain quality of life, by a reduction of associated symptoms and an improvement of physical constitution.

Recent Publications

Management Team

We are a group with multidisciplinary expertise.

Dr. Stephen Wildhirt

CEO, Co-Founder

Cardiothoracic surgeon
with extensive
experience in heart
failure surgery and
cardiac transplantation.

Dr. Andreas Maier


Expert in the
development of image-based personalized
cardiovascular devices
and has extensive
production know-how

Dr. Johannes Clauss


More than 10 years
of experience in medical
device development and
already founded a
medical device start-up.

Dr. Hamman deVaal

Business Development Director

Biomedical engineer with
several years of experience
in business development
and medical device sales
& marketing.

Advisory Board

AdjuCor continuously receives expert advice for the improvement of their heart failure devices.

Prof. Stephan Schüler MD, PhD, FRCS

Consult. Cardiac Surgeon
HOD: Cardiothoracic Surgery,
Head of Mech. Circ. Support,
Freeman Hospital
Newcastle upon Tyne, UK

Prof. Ulrich A. Stock MD

Prof. of Cardiac Surgery
Royal Brompton and
Harefield NHS Trust
Harefield Hospital
Middlesex, UK

Prof. Axel Bauer

Consult. Cardiologist
Head Campus Innenstadt
Medical Clinic I
University Clinic Munich
Munich, Germany

AdjuCor uses imaging data to respect the specific individual anatomy of each patient’s heart. It results in enhanced functionality and efficiency of the cardiac assist devices. The implants are positioned outside the blood stream with no need for device dependent anticoagulation. This results in the reduction of risk for stroke and bleeding, both being the predominant causes for re-hospitalization.

Cooperative Projects / Partner

AdjuCor benefits from various cooperative R&D projects with partners from academia and industry.

Public Support and Funding

Within the cooperative projects with their scientific partners, AdjuCor is funded and supported by the German Ministry of Education and Research, the German Ministry of Economic Affairs and Energy, the State of Bavaria and the European Union.


Unsolicited applications are welcome.

AdjuCor is a high-tech medical technology company. We are continuously looking for specialists from medicine, biotechnology, mechanical and electronic engineering that are interested in the research and development of medical device technology.

Contact / Imprint

If you have any questions or need information, please call or email us:

AdjuCor GmbH

Managing Director: Professor Dr. med. Stephen Wildhirt
HRB: 183620
UId: DE 271301817